[PDF][PDF] Utility of cardiac biomarkers and biosensors for diagnosis of acute myocardial infarction

R Shinde, I Juwarwala, V Modi… - Global Transl …, 2023 - api-journal.accscience.com
Acute myocardial infarction (AMI) is the most prevalent condition that results in sickness and
death worldwide. An early and accurate diagnosis of AMI is critical for prompt and …

[HTML][HTML] Advances in research on biomarkers associated with acute myocardial infarction: A review

X Huang, S Bai, Y Luo - Medicine, 2024 - journals.lww.com
Acute myocardial infarction (AMI), the most severe cardiovascular event in clinical settings,
imposes a significant burden with its annual increase in morbidity and mortality rates …

Diagnostic markers of acute myocardial infarction

S Mythili, N Malathi - Biomedical reports, 2015 - spandidos-publications.com
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. The
highest risk of fatality occurs within the initial hours of onset of AMI. Thus, early diagnosis of …

Proteomic biomarkers for diagnosis in acute myocardial infarction

JP Park, MK Park, JW Yun - Biomarkers, 2011 - Taylor & Francis
Acute myocardial infarction (AMI) is considered the leading cause of morbidity and mortality
in many industrialized nations. AMI is defined currently by detection of a rise and/or fall of …

[HTML][HTML] Traditional and novel diagnostic biomarkers for acute myocardial infarction

H Khalil - The Egyptian Journal of Internal Medicine, 2022 - Springer
Background Acute myocardial infarction (AMI) is a leading cause of death worldwide. The
first hours of acute myocardial infarction are correlated with the highest risk of death …

[HTML][HTML] From classic to modern prognostic biomarkers in patients with acute myocardial infarction

C Stătescu, L Anghel, BS Tudurachi, A Leonte… - International Journal of …, 2022 - mdpi.com
Despite all the important advances in its diagnosis and treatment, acute myocardial
infarction (AMI) is still one of the most prominent causes of morbidity and mortality …

Cardiac Biomarkers for Better Management of Acute Coronary Syndromes.

I Sathyamurthy, JJ Dalal, JP Sawhney… - The Journal of the …, 2015 - europepmc.org
Acute myocardial infarction (AMI) causes significant mortality and morbidity. Timely
diagnosis allows clinicians to risk stratify their patients and select appropriate treatment …

[PDF][PDF] Clinical significance and effectiveness of various serum biomarkers in diagnosis of myocardial infarction

H Kaur, S Gupta, M Verma, K Singh, J Singh - Int J Bioassays, 2013 - Citeseer
Myocardial infarction (MI) causes significant mortality and morbidity. Timely diagnosis allows
clinicians to risk stratify their patients and select appropriate treatment. Biochemical markers …

[HTML][HTML] Cardiac Biomarkers

S Patibandla, K Gupta, K Alsayouri - StatPearls, 2023 - statpearls.com
Cardiac biomarkers are endogenous substances released into the bloodstream when the
heart muscle is damaged or stressed.[1] Measurement of these biomarkers is used to help …

Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1

AM Chaulin, DV Duplyakov - Journal of Clinical Practice, 2020 - journals.eco-vector.com
The morbidity and mortality rates for acute myocardial infarction (AMI) have been growing
rapidly in the recent years, causing a significant socio-economic damage. The cardiospecific …